Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Revenue

Emcure Pharmaceuticals had revenue of 25.80B INR in the quarter ending June 30, 2026, with 22.85% growth. This brings the company's revenue in the last twelve months to 96.83B, up 18.36% year-over-year. In the fiscal year ending March 31, 2026, Emcure Pharmaceuticals had annual revenue of 92.04B with 16.56% growth.

• Revenue (ttm): 96.83B
• Revenue Growth: +18.36%
• P/S Ratio: 3.65
• Revenue / Employee: 14.39M
• Employees: 6,731
• Market Cap: 353.21B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	92.04B	13.08B	16.56%
Mar 31, 2025	78.96B	12.38B	18.59%
Mar 31, 2024	66.58B	6.72B	11.23%
Mar 31, 2023	59.86B	1.30B	2.23%
Mar 31, 2022	58.55B	8.22B	16.33%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error